Loading stock data…
SPTX
$17.66+1.46 (+9.01%)
Pre-Market$17.01-0.65 (-3.68%)· Last close Jun 9
Seaport Therapeutics, Inc.
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Quarterly Financials
| Metric (USD) | Q1 2026 |
|---|---|
| Total Revenue | $0 |
| Gross Profit | — |
| Operating Income | -$87.29M |
| Net Income | -$74.88M |
Peer Comparison
JNJUNHPFE
Fundamentals
Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$945.35M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
148,181
